CIK 0001533040 · Non-accelerated filer<br>Smaller reporting company
Phio Pharmaceuticals Corp.
Sign in to watch- Ticker
- PHIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 453215903
- Phone
- (508) 767-3861
- Business address
- 411 SWEDELAND ROAD, SUITE 23-1080, KING OF PRUSSIA, PA, 19406
- Former names
- RXi Pharmaceuticals Corp
- Open-market buys, last 90 days
- $104,806
- in 9 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$104,806. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 55 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-09 | Plott Ronald Todd Director | Purchase | +18,300 | $0.83 | $15K | 60,300 |
| 2026-09-29 | Plott Ronald Todd Director | Purchase | +5,000 | $1.04 | $5K | 42,000 |
| 2026-09-28 | Plott Ronald Todd Director | Purchase | +5,000 | $1.03 | $5K | 37,000 |
| 2026-09-28 | Plott Ronald Todd Director | Grant or award | +17,000 | 32,000 | ||
| 2026-08-19 | Plott Ronald Todd Director | Purchase | +15,000 | $1.14 | $17K | 15,000 |
Page 1 of 1 · 5 trades